OXER1 (aa212-261) IHC-plus Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-OXER1 (aa212-261) IHC-plus antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityOXER1 (aa212-261) IHC-plus
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieshuman
Isotypen/a
Formatimmunoaffinity purified
Size0.05 mL
Concentration1 mg/ml
ApplicationsImmunohistochemistry (IHC) Paraffin, Immunofluorescence (IF), Western Blot (WB), ELISA (EIA)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionSpecificity: OXER1 Antibody detects endogenous levels of total OXER1 protein. OXER1 Antibody, GPR170 Antibody, G-protein coupled receptor 170 Antibody, HEOAD54 Antibody, Oxoeicosanoid (OXE) receptor 1 Antibody, Oxoeicosanoid receptor 1 Antibody, TG1019 Antibody Description: Receptor for eicosanoids and polyunsaturated fatty acids such as 5-oxo-6E,8Z,11Z,14Z-eicosatetraenoic acid (5-OXO-ETE), 5(S)-hydroperoxy-6E,8Z,11Z,14Z-eicosatetraenoic acid (5(S)-HPETE) and arachidonic acid. Seems to be coupled to the G(i)/G(o), families of heteromeric G proteins.
ImmunogenImmunogen: OXER1 antibody was raised against synthetic peptide from human OXER1 (aa212-261). Immunogen Description: Synthetic peptide from human OXER1 (aa212-261).
Other Names[Rabbit (IgG) to Human OXER1; Human OXER1; GPR170; G-protein coupled receptor 170; HEOAD54; Oxoeicosanoid (OXE) receptor 1; Oxoeicosanoid receptor 1; TG1019]
Gene, Accession #[OXER1], Gene ID: 165140, NCBI: NP_683765.1, UniProt: Q8TDS5
Catalog #MBS2400200
Price$530
Order / More InfoOXER1 (aa212-261) IHC-plus Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.